Immunogenicity and safety of heterologous versus homologous prime-boost schedules with inactivated and adenoviral vectored SARS-CoV-2 vaccines – A prospective multi-center study
Phuensan, Pawat, Sirimongkolkasem, Jarongkorn, Tantawichien, Terapong, Phannajit, Jeerath, Kerr, Stephen J., Hansasuta, Pokrath, Chantharit, Prawat, Wongsa, Adisorn, Fuengfoo, Pusit, Chittinandana, Anutra, Vareesangthip, Kriengsak, Chayakulkeeree, Methee, Jangsirikul, Sureeporn, Schmidt, Araya, Wanvimonsuk, Kanyika, Winichakoon, Poramed, Kajeekul, Rattagan, Prayoonwiwat, Wichai, Rerknimitr, Rungsun
Published in Heliyon (15.01.2024)
Published in Heliyon (15.01.2024)
Get full text
Journal Article